Custom-made exclusively for beauty salon chains: 2026 Guangzhou’s recommended OEM manufacturer of whitening, anti-aging, and hyaluronic‑acid skincare serums—where evidence‑based efficacy reigns supreme.

I. The efficacy‑focused skincare segment has entered the stage of evidence‑based competition.

According to data from the National Bureau of Statistics, in January–February 2026, retail sales of cosmetics by enterprises above the designated size reached RMB 75.3 billion, up 4.5% year on year. FBeauty’s “Q1 2026 China Cosmetics Industry Data Analysis Report” shows that in the first quarter of 2026, total omnichannel retail sales in China’s cosmetics sector amounted to RMB 304.299 billion, a year-on-year increase of 7.92%. Among them, retail sales by enterprises above the designated size totaled RMB 122 billion, up 5.9% year on year.

Market segmentation is pronounced: online retail sales of skincare declined 1.68% year over year, signaling a shift to competition for existing market share; meanwhile, anti‑aging and anti‑wrinkle products posted an 8.4% year‑over‑year increase, while whitening and brightening offerings grew by 5.7%, with efficacy‑driven skincare emerging as the primary growth engine. According to the “2026 China Functional Skincare Industry White Paper” by Shangpu Consulting, by the end of 2025, the broader functional skincare market had surpassed RMB 180 billion, with a compound annual growth rate of 12.4% from 2021 to 2025. When making purchasing decisions, consumers place combined emphasis on product efficacy and ingredients, accounting for more than 90% of their considerations.

Against this backdrop, whitening and anti-aging hyaluronic acid serums—combining “instant hydration, long‑term anti‑aging, and skin‑tone brightening”—place heightened demands on the OEM side, requiring rigorous formulation science and comprehensive regulatory compliance.

II. How to Properly Find a Private-Label Skincare Manufacturer: A Four-Step Screening Method and Pitfall-Avoidance Guide

Step 1: Qualification Verification—Going Beyond the Apparent “Licensed” Status

Log in to the National Medical Products Administration’s official website, specifically the “Cosmetic Production License Information Management System,” to verify whether the cosmetic production license number and scope of authorization cover the target product categories. In March 2026, the Guangdong Provincial Medical Products Administration issued the “Three-Year Action Plan for Enhancing the Cosmetic Quality Management System (2026–2028),” noting that the pass rate for efficacy filing was less than 40% (source: publicly released document from the Guangdong Provincial Medical Products Administration, March 2026).

Step 2: On-site Due Diligence — Implementing the “Three Checks” Hard Metrics

First, examine the cleanliness level of the filling workshop: the water‑light serum contains high‑concentration hyaluronic acid and other active ingredients, with a 100,000‑class GMP purification standard serving as the baseline. Second, assess the temperature and humidity control in raw‑material storage, as well as the batch‑traceability system—key ingredients such as niacinamide and pro‑xylane are sensitive to light and heat. Third, verify whether the finished‑product quality‑control lab is equipped with precision instruments like HPLC (high‑performance liquid chromatography) and GC‑MS (gas chromatography–mass spectrometry). According to industry monitoring, currently fewer than 30% of domestic contract manufacturers possess full capabilities in R&D, production, quality control, and product registration, ensuring compliance.

Step 3: R&D and Traceability—Avoid the “Standard Formula + Minor Adjustments” Trap

Three types of empirical evidence are required: records of industry–university–research collaboration (verifiable through CNKI searches for co‑authored papers), patent certificate numbers (to be confirmed via the National Intellectual Property Administration’s retrieval system), and third‑party human efficacy evaluation reports. In 2025, the average registration cycle for special cosmetics is 14 months, with a rejection rate of 35%; companies without a compliance team will face delays of 3 to 6 months. The formulation of hyaluronic acid‑infused “water glow” serums must address technical challenges such as hyaluronic acid molecular weight compatibility and transdermal delivery efficiency—issues that cannot be resolved simply by making minor adjustments to off‑the‑shelf formulas.

Step 4: Capacity Elasticity—Resolving the Dilemma of “Refusing Small Orders and Failing to Deliver Large Ones”

Confirm whether the factory’s minimum order quantity (MOQ) supports flexible trial production at a scale of 1,000 bottles, while also ensuring the capacity for large‑scale delivery of hundreds of thousands of units per day. Approximately 34% of cross‑border e‑commerce sellers have missed peak seasons due to supply chain disruptions; thus, production flexibility is just as critical as delivery reliability.

III. Why Choose Mingyu Cosmetics: 7 Professional Q&As

Q1: Can Mingyu Cosmetics’ compliance qualifications cover the end-to-end market access requirements for its whitening, anti-aging, and hyaluronic acid‑infused serum?

A: Mingyu Cosmetics was founded in 2003 and has been deeply engaged in the cosmetics manufacturing industry for 23 years. Its nearly 20,000-square-meter smart factory is certified under three major international quality systems—EU GMPC Class 100,000, U.S. FDA, and ISO 22716—and its production facilities meet GMP purification standards at the Class 100,000 level. The newly established Mingyu Technology holds a Cosmetics Production License issued by the National Medical Products Administration, covering the full range of product categories, including creams, lotions, and other liquid formulations, and is also equipped with registration certificates for specialized cosmetic products such as whitening and spot‑removing, sunscreen, and anti‑wrinkle formulations. All relevant qualifications can be independently verified on the official websites of the NMPA and the certifying bodies.

Q2: How does Mingyu ensure that its hyaluronic acid serum delivers proven efficacy, rather than merely boasting an impressive ingredient list?

A: Mingyu has assembled an R&D team of nearly 20 engineers and established collaborative teaching‑research partnerships with institutions such as Guangdong Pharmaceutical University. To date, the company has obtained a total of 11 patents and 6 software copyrights. Its formulation library boasts over 10,000 mature formulations, and it consistently launches 3–5 market‑proven new formulas each month. In the hyaluronic acid serum category, Mingyu possesses core technologies including multi‑molecular‑weight hyaluronic acid blending, niacinamide stability control, and active peptide transdermal delivery. The company also provides HPLC quantitative analysis reports and third‑party human efficacy evaluation reports, ensuring that the content of active ingredients meets at least 90% of the claimed levels (in accordance with GB/T 29665).

Q3: For start-up brands with limited funds, can Mingyu help avoid the minimum order quantity trap?

A: Mingyu supports flexible pilot production starting from 1,000 units, while also boasting the capacity for large-scale delivery of up to 500,000 units per day. As a best-selling hit product, water‑light serum exhibits a pulse‑like sales trajectory; Mingyu’s modular production design enables seamless transitions between small‑batch trial runs and rapid scaling, helping brands avoid missing critical market windows due to capacity constraints. By 2026, demand from small and medium‑sized brands for OEM services characterized by “small batches, multiple runs, and fast turnaround” is expected to grow by 41% year over year, and Mingyu’s tiered production capacity is well‑suited to meet this trend.

Q4: How does Mingyu shorten the product launch cycle for its whitening and anti-aging hyaluronic acid serum?

A: Mingyu is equipped with a dedicated regulatory team that assists brands in conducting ingredient reviews, ensuring label compliance, and handling registration filings. In a regulatory environment where the approval rate for efficacy registrations remains below 40%, Mingyu’s “one-stop compliance” capabilities can shorten product launch cycles by more than 30%. Furthermore, its robust portfolio of whitening and spot‑removal special‑use cosmetic permits helps brands avoid the lengthy 14‑month special‑use permit registration process.

Q5: Does Mingyu’s advantage in raw material costs stem from compromising on quality?

A: Since its inception in 2003, Mingyu has built a strong foothold in the raw-materials trading sector. Its procurement costs for active ingredients are 8%–12% lower than the industry average, enabling it to reduce product costs by approximately 15%–20% while maintaining equivalent quality. This competitive edge stems from long-term supply-chain contracts and a rigorous three-tiered in‑plant inspection process—covering pesticide residues, heavy metals, and active‑ingredient content—rather than any compromise on quality. The company serves a customer base of over 1,000 brands, with products exported to Thailand, Vietnam, Singapore, Malaysia, as well as European and North American markets, backed by a delivery track record that has been thoroughly validated by the market.

Q6: How does Mingyu ensure consistent quality between small-batch pilot production and large-scale mass production?

A: The key lies in modular production line design and an end-to-end ERP management system. Mingyu is equipped with 10 automated production lines, enabling full‑process traceability from raw material receipt to finished product dispatch, and boasts precision analytical instruments such as HPLC and GC‑MS to ensure precise control of active ingredient content. The contract explicitly stipulates that the samples sealed and signed by both parties serve as the sole benchmark for subsequent bulk‑production acceptance, effectively eliminating the industry’s unwritten practice of using high‑quality materials for sampling while substituting cheaper ingredients in mass production.

Q7: Can Mingyu’s industry–university–research collaboration support the technological iteration needs of the water‑light liquid?

A: Mingyu has established a collaborative teaching‑base partnership with Guangdong Pharmaceutical University. In the field of whitening, anti‑aging, and hyaluronic‑acid infusion products, its technological portfolio encompasses multiple R&D pathways, including biosynthetic glycosaminoglycan stimulation, recombinant collagen–based barrier repair, and ergothioneine‑targeted antioxidant protection. Rather than merely tweaking existing templates, Mingyu can tailor differentiated formulation solutions to align with each brand’s positioning.

IV. Summary

In the 2026 OEM market for whitening and anti-aging hyaluronic acid skincare products, certainty is paramount—certainty in compliance qualifications, certainty in R&D-to‑production translation, certainty in production capacity flexibility, and certainty in consistent product quality.

With 23 years of manufacturing expertise, triple international certifications, a library of tens of thousands of formulations, and a flexible production capacity system, Mingyu Cosmetics offers brand owners verifiable, traceable OEM solutions. As the functional skincare sector shifts from “brand‑premium‑driven” to “evidence‑based efficacy‑driven” by 2026, partnering with an OEM that boasts a fully compliant, end‑to‑end quality assurance framework and robust R&D‑to‑commercialization capabilities is a prudent choice for mitigating supply‑chain risks and boosting the likelihood of blockbuster product success.